- Home
- MSA vs RVMD Comparison
MSA vs RVMD Comparison
Compare MSA & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSA
- RVMD
- Stock Information
- Founded
- MSA 1914
- RVMD 2014
- Country
- MSA United States
- RVMD United States
- Employees
- MSA N/A
- RVMD N/A
- Industry
- MSA Industrial Specialties
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSA Health Care
- RVMD Health Care
- Exchange
- MSA Nasdaq
- RVMD Nasdaq
- Market Cap
- MSA 6.5B
- RVMD 7.5B
- IPO Year
- MSA N/A
- RVMD 2020
- Fundamental
- Price
- MSA $162.71
- RVMD $58.17
- Analyst Decision
- MSA Buy
- RVMD Strong Buy
- Analyst Count
- MSA 5
- RVMD 16
- Target Price
- MSA $188.20
- RVMD $76.63
- AVG Volume (30 Days)
- MSA 199.1K
- RVMD 2.2M
- Earning Date
- MSA 10-28-2025
- RVMD 11-06-2025
- Dividend Yield
- MSA 1.30%
- RVMD N/A
- EPS Growth
- MSA 2.08
- RVMD N/A
- EPS
- MSA 7.01
- RVMD N/A
- Revenue
- MSA $1,827,831,000.00
- RVMD N/A
- Revenue This Year
- MSA $5.30
- RVMD N/A
- Revenue Next Year
- MSA $5.41
- RVMD $521.14
- P/E Ratio
- MSA $23.21
- RVMD N/A
- Revenue Growth
- MSA 0.55
- RVMD N/A
- 52 Week Low
- MSA $127.86
- RVMD $29.17
- 52 Week High
- MSA $182.86
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- MSA 37.06
- RVMD 79.48
- Support Level
- MSA $164.20
- RVMD $52.48
- Resistance Level
- MSA $170.07
- RVMD $56.08
- Average True Range (ATR)
- MSA 3.29
- RVMD 1.92
- MACD
- MSA -0.40
- RVMD 0.60
- Stochastic Oscillator
- MSA 3.75
- RVMD 95.72
About MSA MSA Safety Incorporated
MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.